Login / Signup

Review article: Recommendations for detection, assessment and management of suspected drug-induced liver injury during clinical trials in oncology patients.

Anna FettiplaceJohn MarcinakMichael MerzHui-Talia ZhangLuciana KikuchiArie RegevMelissa PalmerDon C RockeyRobert FontanaPaul H HayashiHans L TillmannAdrian M Di BisceglieJames H Lewis
Published in: Alimentary pharmacology & therapeutics (2024)
This review brings together evidence-based recommendations and expert opinion to provide the first dedicated consensus for best practices in detection, assessment, and management of DILI in oncology clinical trials.
Keyphrases